• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 11500
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001)
Patient Problem Fever (1858)
Event Date 02/07/2024
Event Type  Injury  
Manufacturer Narrative
Pictures of the explanted valve were reviewed.Report of infection issue was unable to be confirmed through image evaluation.Image 1 and 2 showed the outflow aspect of an explanted valve.Image 3 showed the inflow aspect of an explanted valve.What appeared to be host tissue (minimal) overgrowth was noted on the stent circumference at both the inflow and outflow aspects.Suture holes were visible around the sewing ring.No other visible inconsistencies were observed from the valve.The device was not returned because it was sent for culture analysis to hospital pathology.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
Edwards received notification that a valve model 11500a25 implanted in the aortic position was explanted from a 48-year-old patient after an implant duration of six (6) months due to concerns of infection, however no endocarditis on the valve was suspected.Additionally, culture analysis was performed at hospital and pathology report came back negative from all culture growth after 10 days.Thus, there was no explanation of why the valve needed to be explanted.The patient presented with fever after an implant duration of sixty-seven (67) days and had multiple rounds of antibiotics which cured the patient.However, the fever returned and decision was made to explant the device.As reported, the patient had no signs of cardiac insufficiency and was not symptomatic.Additionally, the valve did not present regurgitation or stenosis, and at imaging tests it was shown to have normal functionality.The valve was explanted and another valve of the same model and size was implanted in replacement.At explant, the valve showed no signs of svd, no vegetations or abscesses.The patient was noted as to be recovering.
 
Manufacturer Narrative
Added information to section h6 (type of investigation), h6 (investigation findings) and h6 (investigations conclusions) corrected data h6 (device code): "4001 - patient device interaction problem" code removed.H10: additional manufacturer narrative: the subject device was not returned for evaluation.The device history record (dhr) was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.There is no allegation of a malfunction which could be related to a manufacturing non-conformance and/or one was not suspected or confirmed through investigation; no labeling non-conformance/deficiency; no use-related issue with a hazardous situation; no device-related infection; and no evidence of a product failure with regard to design, reliability, or use error.The instructions for use (ifu) have been reviewed and no inadequacies have been identified with regard to warnings, contraindications, and the directions/conditions for the successful use of the device.The reported type of event is included in the ifu.A definitive root cause cannot be conclusively determined; however, patient factors likely caused or contributed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS INSPIRIS RESILIA AORTIC VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
Manufacturer Contact
saurav singh
1 edwards way
mle fl2 office m2013
irvine, CA 92614
9492506615
MDR Report Key18805616
MDR Text Key336509400
Report Number2015691-2024-01445
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/29/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number11500
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received03/27/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/08/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization; Life Threatening;
Patient Age48 YR
Patient SexMale
-
-